M. Curtis

Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease

S. Saito, A. Baumbach, J. Wykrzykowska, 2021 .

Safety and Efficacy of the Supreme Biodegradable Polymer Sirolimus-Eluting Stent in Patients With Diabetes Mellitus

S. Saito, A. Baumbach, M. Leon, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy

S. Saito, A. Baumbach, M. Leon, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease

S. Saito, A. Baumbach, J. Wykrzykowska, 2021, Circulation.

Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment

D. Stewart, S. Archer, J. Grégoire, 2006, Gene Therapy.

The Supreme Biodegradable Polymer DES in Acute and Chronic Coronary Syndromes: A PIONEER III Substudy

S. Saito, A. Baumbach, M. Leon, 2023, Journal of the Society for Cardiovascular Angiography & Interventions.

Geographic Variations on the Safety and Efficacy of the Supreme Biodegradable Polymer DES: Results From PIONEER III

A. Baumbach, S. Windecker, A. Lansky, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.